Dexmedetomidine Infusion as a Novel Supportive Therapy for Fluphenazine-Induced Neuroleptic Malignant Syndrome in a 10-Year-Old Boy: A Case Report and Review of Literature-Reference-Cited by-同舟云学术

Dexmedetomidine Infusion as a Novel Supportive Therapy for Fluphenazine-Induced Neuroleptic Malignant Syndrome in a 10-Year-Old Boy: A Case Report and Review of Literature

Published:2020-12-18 Issue:06 Volume:19 Page:425-427
ISSN:1304-2580
Container-title:Journal of Pediatric Neurology
language:en
Short-container-title:Journal of Pediatric Neurology

Author:

Yu Caroline¹,Kaul Rajat²,Ostwani Waseem³

Affiliation:

1. Department of Pediatrics, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States

2. Department of Pediatrics, Division of Pediatric Hospitalist Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States

3. Department of Pediatrics, Division of Pediatric Critical Care Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States

Abstract

AbstractA 10-year-old male child patient developed symptoms of neuroleptic malignant syndrome (NMS) 1 month following initiation of fluphenazine for behavioral therapeutic management. Dexmedetomidine infusion was able to adequately control the symptoms of NMS with resolution of encephalopathy. This was the first report of novel dexmedetomidine utilization for the treatment of NMS. We suggest using dexmedetomidine as an adjunctive agent to control NMS symptomatology without attendant risk of respiratory depression.

Publisher

Georg Thieme Verlag KG

Subject

Neurology (clinical),Pediatrics, Perinatology and Child Health

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0040-1721380.pdf

Reference24 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. Neuroleptic malignant syndrome in children;A Numa;Med J Aust,1991

3. Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia;G L Stimmel;Clin Ther,2002

4. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis;M Belvederi Murri;Drugs R D,2015

5. Risperidone-induced neuroleptic malignant syndrome;R Sharma;Ann Pharmacother,1996

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal;Cureus;2023-10-15

2. Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report;World Journal of Clinical Cases;2022-01-14

3. Dantrolene/fluphenazine/risperidone;Reactions Weekly;2021-01